Bifidobacterium animalis subsp. Lactis MY9 and application thereof in preparation of anti-inflammatory and hypoglycemic food drugs
The invention belongs to the technical field of probiotics and application thereof, and particularly relates to bifidobacterium animalis subsp. Lactis MY9 and application thereof in preparation of anti-inflammatory and hypoglycemic foods and drugs. According to the invention, the bifidobacterium ani...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention belongs to the technical field of probiotics and application thereof, and particularly relates to bifidobacterium animalis subsp. Lactis MY9 and application thereof in preparation of anti-inflammatory and hypoglycemic foods and drugs. According to the invention, the bifidobacterium animalis subsp. Lactis MY9 strain is separated and purified from feces of a healthy adult in Guangdong province in China, and the strain not only can generate and secrete 3-hydroxybutyric acid, but also can inhibit the activity of alpha-glucosidase, and has the effects of resisting inflammation and improving intestinal flora; the functions of reducing blood sugar, losing weight and the like are realized. Therefore, the newly separated bifidobacterium animalis subsp. Lactis MY9 strain has various probiotic effects, can be used in the fields of anti-inflammation, blood sugar reduction and the like, and has important application value and economic value.
本发明属于益生菌及其应用技术领域,具体涉及一株动物双歧杆菌乳亚种MY9及其在制备抗炎和降血糖食品药品中的应用。本发明从中国广东省一名健 |
---|